Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets
about
Proteomic study of different culture medium serum volume fractions on RANKL-dependent RAW264.7 cells differentiating into osteoclastsIn vitro and in vivo model systems used in prostate cancer research.High SPARC Expression Starting from Dysplasia, Associated with Breast Carcinoma, Is Predictive for Bone Metastasis without Enhancement of Plasma LevelsBiomarker Studies in Early Detection and Prognosis of Breast Cancer.Stromal cells in breast cancer as a potential therapeutic target.
P2860
Molecular pathogenesis of bone metastases in breast cancer: Proven and emerging therapeutic targets
description
2014 nî lūn-bûn
@nan
2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@ast
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@en
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@nl
type
label
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@ast
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@en
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@nl
prefLabel
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@ast
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@en
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@nl
P2093
P2860
P356
P1476
Molecular pathogenesis of bone ...... d emerging therapeutic targets
@en
P2093
Edoardo Alesse
Patrizia Sanità
Simona Delle Monache
P2860
P304
P356
10.5306/WJCO.V5.I3.335
P577
2014-08-01T00:00:00Z